Trends In Cold Chain Storage For Biologics
Source: W.L. Gore & Associates
By Joe Cintavey, product specialist, Gore PharmBIO Products
Packaging is critical, as biotechnology products become more valuable and require colder storage.
It is an exciting time for the biologics industry as new vaccines, monoclonal antibodies, mRNA therapies (or RNA therapies) and cell and gene therapies rapidly move into clinical use. These drugs are helping fight COVID-19 and providing completely new treatment options for diseases like cancer.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
W.L. Gore & Associates
This website uses cookies to ensure you get the best experience on our website. Learn more